Oct 17 (Reuters) – Azurity Pharmaceuticals: * AZURITY PHARMACEUTICALS: ANNOUNCES FDA APPROVAL OF FERABRIGHT (TM) (FERUMOXYTOL INJECTION)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)